Your browser is no longer supported. Please, upgrade your browser.
Settings
SYNH Syneos Health, Inc. daily Stock Chart
SYNH [NASD]
Syneos Health, Inc.
Index- P/E36.11 EPS (ttm)1.82 Insider Own0.50% Shs Outstand104.28M Perf Week-1.08%
Market Cap6.75B Forward P/E15.82 EPS next Y4.16 Insider Trans-98.62% Shs Float61.25M Perf Month23.81%
Income192.00M PEG3.50 EPS next Q1.11 Inst Own- Short Float9.26% Perf Quarter6.31%
Sales4.49B P/S1.50 EPS this Y467.60% Inst Trans-0.82% Short Ratio7.56 Perf Half Y5.86%
Book/sh29.69 P/B2.21 EPS next Y22.06% ROA2.60% Target Price75.08 Perf Year19.73%
Cash/sh2.42 P/C27.12 EPS next 5Y10.30% ROE6.30% 52W Range30.02 - 74.25 Perf YTD10.50%
Dividend- P/FCF16.08 EPS past 5Y34.80% ROI4.90% 52W High-16.19% Beta1.85
Dividend %- Quick Ratio1.10 Sales past 5Y31.70% Gross Margin22.50% 52W Low107.30% ATR2.62
Employees24000 Current Ratio1.10 Sales Q/Q-6.60% Oper. Margin6.30% RSI (14)49.65 Volatility3.42% 4.07%
OptionableYes Debt/Eq0.83 EPS Q/Q7.10% Profit Margin4.30% Rel Volume4.57 Prev Close65.72
ShortableYes LT Debt/Eq0.81 EarningsOct 29 BMO Payout0.00% Avg Volume750.49K Price62.23
Recom1.90 SMA20-1.72% SMA505.01% SMA2009.02% Volume1,999,471 Change-5.31%
Oct-06-20Upgrade Mizuho Neutral → Buy $65
Oct-01-20Upgrade Goldman Neutral → Buy $69 → $75
Mar-30-20Downgrade Goldman Buy → Neutral $79 → $45
Jan-07-20Initiated Citigroup Buy $75
Oct-19-18Upgrade William Blair Mkt Perform → Outperform
Oct-09-18Initiated UBS Buy
Oct-04-18Initiated Evercore ISI Outperform $58
Dec-02-20 08:30AM  
Dec-01-20 04:21PM  
Nov-30-20 11:42AM  
Nov-25-20 03:36AM  
Nov-24-20 06:07PM  
Nov-18-20 06:52PM  
07:22AM  
Nov-17-20 08:40AM  
Nov-16-20 08:43AM  
Nov-13-20 08:15AM  
Nov-12-20 08:56AM  
07:30AM  
Nov-03-20 08:19AM  
Nov-02-20 05:20PM  
10:43AM  
Oct-30-20 01:08PM  
Oct-29-20 07:59AM  
07:35AM  
06:13AM  
06:00AM  
Oct-28-20 05:39PM  
Oct-22-20 12:33PM  
Oct-21-20 06:30AM  
Oct-19-20 06:30AM  
Oct-13-20 08:45AM  
Oct-07-20 11:45AM  
Oct-05-20 04:58PM  
Sep-28-20 09:59AM  
Sep-16-20 06:20PM  
04:52PM  
08:52AM  
Sep-15-20 04:51PM  
Sep-10-20 02:42PM  
Sep-09-20 10:55AM  
Sep-05-20 11:32AM  
Sep-02-20 07:30AM  
Sep-01-20 08:12AM  
Aug-11-20 09:50AM  
Aug-06-20 09:45AM  
06:14AM  
Jul-30-20 12:33PM  
Jul-20-20 11:02AM  
Jul-13-20 08:30AM  
Jul-11-20 05:42PM  
03:46PM  
Jul-07-20 08:00AM  
Jul-01-20 03:37PM  
Jun-22-20 08:42AM  
Jun-19-20 09:38AM  
Jun-17-20 01:52PM  
11:08AM  
Jun-16-20 08:43AM  
08:39AM  
May-30-20 11:31AM  
May-28-20 08:30AM  
May-22-20 08:39AM  
May-13-20 12:15PM  
May-04-20 10:26AM  
Apr-30-20 06:00PM  
07:55AM  
06:34AM  
Apr-23-20 12:32PM  
Apr-07-20 06:54AM  
Apr-03-20 04:17PM  
Apr-02-20 02:54PM  
Apr-01-20 02:31PM  
Mar-30-20 12:09PM  
Mar-27-20 05:13PM  
10:28AM  
Mar-25-20 07:09AM  
Mar-21-20 11:30AM  
Mar-17-20 09:27AM  
Mar-05-20 04:05PM  
Feb-28-20 08:41AM  
08:07AM  
Feb-25-20 01:59PM  
Feb-24-20 02:59PM  
Feb-21-20 07:46AM  
06:43AM  
Feb-20-20 02:46PM  
07:55AM  
06:20AM  
06:00AM  
Feb-19-20 06:56AM  
Feb-13-20 12:31PM  
Jan-22-20 09:00AM  
Jan-20-20 12:59PM  
Jan-09-20 07:00AM  
Jan-08-20 08:01AM  
Jan-03-20 06:00PM  
Dec-30-19 09:31AM  
Dec-11-19 03:56PM  
Dec-09-19 09:15AM  
08:42AM  
Dec-02-19 09:30AM  
Nov-21-19 09:02AM  
Nov-20-19 09:10AM  
Nov-13-19 03:39PM  
08:00AM  
Nov-12-19 04:30PM  
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meggs Jason M.Chief Financial OfficerNov 27Sale67.004,062272,15466,003Nov 30 05:12 PM
Meggs Jason M.Chief Financial OfficerNov 24Sale67.001,938129,84670,065Nov 25 05:01 PM
KEEFE MICHELLEPres., Commercial SolutionsNov 18Sale65.0085655,64048,881Nov 19 05:00 PM
KEEFE MICHELLEPres., Commercial SolutionsNov 17Sale62.6580050,12049,643Nov 19 05:00 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerSep 17Sale59.263,766,281223,189,81218,647,036Sep 21 09:56 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerSep 17Sale59.263,766,281223,189,81218,647,036Sep 21 09:56 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerSep 17Sale59.263,766,281223,189,81218,647,036Sep 21 09:55 PM
Allen TomDirectorSep 17Sale59.263,766,281223,189,81218,647,036Sep 21 09:55 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerSep 17Sale59.263,766,281223,189,81218,647,036Sep 21 09:55 PM
Maldonado John L.DirectorSep 17Sale59.263,766,281223,189,81218,647,036Sep 21 09:54 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerSep 17Sale59.263,766,281223,189,81218,647,036Sep 21 09:54 PM
ADVENT INTERNATIONAL CORP/MA10% OwnerSep 17Sale59.263,766,281223,189,81218,647,036Sep 21 09:53 PM
THOMAS H. LEE ADVISORS, LLCDirectorSep 17Sale59.263,232,987191,586,81016,006,677Sep 21 05:39 PM
THOMAS H. LEE ADVISORS, LLCDirectorSep 17Sale59.2673243,3781,005Sep 21 05:39 PM
THOMAS H. LEE ADVISORS, LLCDirectorSep 17Sale59.263,232,987191,586,81016,006,677Sep 21 05:30 PM
THOMAS H. LEE ADVISORS, LLCDirectorSep 17Sale59.2673243,3781,005Sep 21 05:30 PM
Macdonald AlistairChief Executive OfficerAug 03Sale65.0710,289669,464246,687Aug 04 05:06 PM
Macdonald AlistairChief Executive OfficerJul 15Option Exercise16.0637,868608,160280,088Jul 17 05:03 PM
Macdonald AlistairChief Executive OfficerJul 15Sale60.1437,8682,277,495261,154Jul 17 05:03 PM
Macdonald AlistairChief Executive OfficerJul 14Option Exercise10.575,17354,679266,327Jul 15 05:03 PM
Macdonald AlistairChief Executive OfficerJul 14Sale58.685,173303,553261,154Jul 15 05:03 PM
Macdonald AlistairChief Executive OfficerJul 13Option Exercise10.573,65538,633264,809Jul 15 05:03 PM
Macdonald AlistairChief Executive OfficerJul 13Sale58.213,655212,747261,154Jul 15 05:03 PM
Dineen John M.DirectorJul 06Buy59.118,691513,72517,426Jul 08 05:04 PM
KEEFE MICHELLEPres., Commercial SolutionsJul 06Sale59.111,50088,66550,443Jul 08 05:06 PM
KEEFE MICHELLEPres., Commercial SolutionsMay 20Sale60.002,500150,00051,943May 21 05:01 PM
Parks RobertEVP, Chief Accounting OfficerApr 20Sale49.653,588178,14412,450Apr 21 07:04 PM
Meggs Jason M.Chief Financial OfficerMar 20Buy36.743,555130,61363,829Mar 23 05:04 PM
COLVIN PAULPres., Clinical SolutionsMar 19Buy36.651,30047,64526,855Mar 23 05:06 PM
Meggs Jason M.Chief Financial OfficerMar 05Option Exercise0.005,094068,923Apr 15 06:39 PM
Macdonald AlistairChief Executive OfficerMar 05Option Exercise0.0031,2580248,937Apr 15 06:55 PM